Chicago Partners Investment »

Janux Therapeutics shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2024-03-31 $421k 8.5k 49.78
2022-09-30 $181k 11k 17.04
2021-12-31 $188k 11k 16.52
2021-09-30 $235k 9.5k 24.85

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p Mcp Etf (IJH)
Enterprise Products Partners (EPD)
Vanguard Index Fds Growth Etf (VUG)
Energy Transfer Com Ut Ltd Ptn (ET)
Dimensional Etf Trust Us Equity Etf (DFUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus Mdcp Val Etf (IWS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Chicago Partners Investment

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Rtw Investments
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
State Street Corporation
Avidity Partners Management

View all funds holding Janux Therapeutics